VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $781,143 | -45.2% | 50,922 | -15.1% | 0.00% | – |
| Q2 2023 | $1,426,734 | +13.6% | 59,972 | +21.5% | 0.00% | – |
| Q1 2023 | $1,256,000 | +24850.3% | 49,377 | -71.4% | 0.00% | -100.0% |
| Q4 2022 | $5,034 | -99.6% | 172,359 | +148.9% | 0.00% | – |
| Q3 2022 | $1,421,000 | +567.1% | 69,258 | +277.7% | 0.00% | – |
| Q2 2022 | $213,000 | -38.3% | 18,339 | -1.8% | 0.00% | – |
| Q1 2022 | $345,000 | +33.7% | 18,666 | +43.2% | 0.00% | – |
| Q4 2021 | $258,000 | – | 13,033 | +130230.0% | 0.00% | – |
| Q1 2021 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |